Table 3.
Summary of studies examining the effect of Helicobacter pylori infection on colonic microbiota
Detection method | Author, year | Participants | Age | Country | α-diversity | Findings |
---|---|---|---|---|---|---|
Cultivation | Bühling et al., 200198 | 51 H. pylori vs. 27 control | Adult | Germany | N/A | ↓Anaerobes in H. pylori patients; ↓Enterobacteria, Clostridium innocuum and Veillonella spp. in H. pylori patients; ↑Lactobacilli, esp. Lactobacillus acidophilus in H. pylori patients |
Myllyluoma et al., 200799 | 39 H. pylori vs. 19 control | Adult | Finland | N/A | ↓Clostridium histolyticum and anaerobes in H. pylori patients | |
Yang et al., 2012100 | 38 H. pylori vs. 38 matched control | Child | Taiwan | N/A | ↓Bifidobacterium, Bifidobacterium:Escherechia coli ratio; ↑E. coli | |
Benavides-Ward et al., 2018103 | 28 H. pylori vs. 28 control | Child | Peru | N/A | ↑Proteobacteria, Firmicutes and Prevotella in H. pylori patients | |
Next-Generation Sequencing | Chen et al., 2018101 | 70 H. pylori vs. 35 control | Adult | China | ↑ richness (Sobs index) | 22 genera and 38 bacterial species differ; predicted metabolic pathways differ |
Iino et al., 2018102 | 226 H. pylori vs. 524 control (111 non-AG, mild AG, severe AG) | Adult | Japan | N/A | ↑Lactobacillus in severe AG vs. mild & non-AG | |
Gao et al., 2018104 | 24 H. pylori vs. 22 non−H. pylori (negative control + past infection) | Adult | China | Non-significant ↑ Shannon index in gastritis and metaplasia | No differences in β-diversity; some genera differ; ↓Bacteroidetes, ↑Firmicutes and ↑Proteobacteria associated with H. pylori–related gastric lesion progression | |
Osaki et al., 2018105 | 5 H. pylori–infected children and 13 family members | Child and adult | Japan | N/A | No differences in β-diversity and Firmicutes/Bacteroidetes ratio; some genera differ | |
Iino et al., 2019106 | 226 H. pylori vs. propensity score matched control | Adult | Japan | ↑ | β-diversity differs; some genera differ; ↑Streptococcus in severe AG vs. non-AG in H. pylori patients | |
Wang et al., 2019107 | 128 H. pylori vs. 158 control | Adult | China | No differences | β-diversity differs; some genera differ | |
Dash et al., 2019108 | 12 H. pylori vs. 48 control | Adult | United ArabEmirates | ↑ | No difference in β-diversity; some genera differ | |
He et al., 201954 | 17 H. pylori vs. 7 control | Adult | China | ↑ | β-diversity differs; ↑Proteobacteria, Actinobacteria, and Acidobacteria; some genera differ | |
Vasapolli et al., 201947 | 6 H. pylori, 15 non−H. pylori | Adult | Germany | N/A | No differences in β-diversity | |
Yang et al., 2019109 | 50 H. pylori, 42 control | Child | China | No differences | β-diversity differs; some genera differ | |
Frost et al., 2019110 | 212 H. pylori vs. 212 control | Adult | Germany | ↑ | β-diversity differs; some genera differ; more enterotype 2 in H. pylori patients; Bacteroides, Barnesiella, Alistipes, and Fusicatenibacter negatively associated with HpSA load | |
Cornejo-Pareja et al., 2019111 | 40 H. pylori vs. 20 control | Adult | Spain | ↓ | β-diversity differs | |
Zhou et al., 2020112 | 22 H. pylori vs. 23 control | Child | China | No differences | No differences in α-diversity and β-diversity; some genera differ |
AG, atrophic gastritis; N/A, not available; HpSA, Helicobacter pylori stool antigen